HRT Prioritizes Access To Affordable Naloxone As US FDA Approves Second OTC Formulation

Approval in the US of the second OTC product in a drug category typically doesn’t merit mention by the Food and Drug Administration commissioner.

Making opioid overdose treatment naloxone available OTC, however, isn’t a typical approval by the FDA.